SeaChange Grows Leadership Team to Enhance Customer Delivery and Market Expansion

20:00 EDT 12 Aug 2015 | Globe Newswire

ACTON, Mass., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Multiscreen innovator SeaChange International, Inc. (NASDAQ:SEAC) today announced the expansion of its senior management team with the immediate appointment of software, networking and media industry veterans Paul Crann to Senior Vice President of Product Management & Solutions Architecture, and Mitchell Chun to Senior Vice President of Business Development. In these newly created positions, Crann and Chun report to Chief Operating Officer Ed Terino.

"SeaChange continues to sharpen its core competencies in software product creation and market delivery for our video service provider customers through top talent like Paul and Mitchell," said SeaChange CEO Jay Samit. "I'm pleased to welcome Paul to our family and congratulate Mitchell on his promotion. Their focus on optimizing internal resources and expanding strategic alliances globally will strengthen SeaChange's core market performance and enable us to establish our software innovations with broadcasters and emerging OTT providers."

With all SeaChange product management and solutions architecture teams reporting to him, Paul Crann is responsible for facilitating strategy, development and execution for SeaChange's OTT, multiscreen back office, advertising, home gateway and social media analytics products. Crann comes to SeaChange from BTI Systems, a software-driven network solutions provider for telecommunications and content service providers, where he was SVP of Product Marketing & Business Development. His career focus on product execution and business development included senior roles with Ascend Communications, AT&T, Avici Systems, BigBand Networks and Omnipoint Communications. He earned an MBA from Harvard Business School and a BSE from Villanova University, in addition to serving as a submarine officer in the U.S. Navy.

Mitchell Chun joined SeaChange as VP, Business Development upon the acquisition of Timeline Labs in February 2015, bringing the Company over 20 years of technology and media business development experience. As SVP, Business Development, Chun's responsibilities now span evaluation and execution of technology and distribution alliances to strengthen SeaChange's offerings to new geographies and market sectors, as well as supporting the Company's NewCoin television audience measurement joint venture. Prior to co-founding Timeline Labs, Chun held senior development and strategy roles with established market leaders Fox, Universal Pictures and Yahoo, as well as start-ups Zazzle and He earned a BS from the University of California at Berkeley.

Go to to book hands-on solution demonstrations with SeaChange at upcoming television industry conferences including IBC 2015 (Sept. 11-15, Amsterdam), ONA15 (Sept. 24-26, Los Angeles) and Cable-Tec Expo (Oct. 13-16, New Orleans).

About SeaChange International

Enabling our customers to deliver billions of premium video streams across a matrix of pay-TV and OTT platforms, SeaChange (Nasdaq:SEAC) empowers service providers, broadcasters, content owners and brand advertisers to entertain audiences, engage consumers and expand business opportunities. As a three-time Emmy award-winning organization with over 20 years of experience, we give media businesses the content management, delivery, measurement and analytics capabilities they need to craft an individualized branded experience for every viewer that sets the pace for quality and value worldwide. Visit

         Jim Sheehan
         +1-978-897-0100 x3064
         Monica Gould
         The Blueshirt Group

SeaChange International, Inc. logo


More From BioPortfolio on "SeaChange Grows Leadership Team to Enhance Customer Delivery and Market Expansion"

Quick Search


Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...